We’re improving your experience!

×

Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.

Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.

Stay tuned for these updates, and thank you for being part of our community!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05756322
Title The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Lin BioScience, Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins NOT_YET_RECRUITING Baltimore Maryland 21287 United States Details
Wollongong Private Hospital RECRUITING Wollongong New South Wales Australia Details
Pindara Private Hospital RECRUITING Benowa Queensland Australia Details
The Royal Adelaide Hospital RECRUITING Adelaide South Australia Australia Details
The Alfred Hospital RECRUITING Melbourne Victoria Australia Details
Hollywood Private Hospital NOT_YET_RECRUITING Nedlands Western Australia Australia Details
China Medical University Hospital NOT_YET_RECRUITING Taichung Taiwan Details
National Cheng Kung University Hospital NOT_YET_RECRUITING Tainan Taiwan Details
National Taiwan University Hospital NOT_YET_RECRUITING Taipei Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field